Medical device companies have shifted financing sources from early VC to strategic partnerships, and subsequently exits in the form of acquisitions over IPOs. As such, FDA clearance has been overtaken by reimbursement and an effective payer strategy, in which a dossier of supporting peer-reviewed publications is paramount to reimbursement and acquisition. This evening\’s presentation focuses on an effective publication strategy, featuring guest speakers Jon E. Block, PhD., and Natalie DeWitt, PhD. Dr. Block is a worldwide authority on trial design, development and interpretation, who has authored 200+ peer-reviewed articles and serves as a strategic advisor in linking clinical trial objectives with regulatory and reimbursement goals. Dr. DeWitt is an expert in scientific writing, publishing, and funding in the biomedical research arena, with over a decade’s experience as a Nature editor, and a broad base of knowledge in achieving excellence in scientific communication, for effective dissemination of findings, and securing of funding for scientific research.

Knowledge Objectives

•  Timing of publications throughout the product development cycle

•  Full range of article types to consider

•  Controlling the publication process – why publications should be company initiated

•  Strategic publication development – traditional versus open-access journals

•  Optimizing your publication objectives

 

Who should attend?

•  Medical Device

•  Biotech

•  Pharma

•  CRO

•  Clinical

•  Regulatory

•  Health Economics

•  Reimbursement

•  Product Development

•  Medical Communications

•  Marketing

•  Sales and Business Development